Davis R M Inc Thermo Fisher Scientific Inc. Transaction History

Davis R M Inc

$5.09 Billion
Q3 2024

A detailed history of Davis R M Inc transactions in Thermo Fisher Scientific Inc. stock. As of the latest transaction made, Davis R M Inc holds 131,893 shares of TMO stock, worth $69.8 Million. This represents 1.6% of its overall portfolio holdings.

Number of Shares

131,893

Previous 127,668 3.31%

Holding current value

$69.8 Million

Previous $70.6 Million 15.55%

% of portfolio

1.6%

Previous 1.46%

29 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 12, 2024	BUY	$531.86 - $624.21 $2.25 Million - $2.64 Million	4,225 Added 3.31%	131,893 $81.6 Million
Q2 2024 Aug 09, 2024	SELL	$541.52 - $599.02 $1.46 Million - $1.61 Million	-2,688 Reduced 2.06%	127,668 $70.6 Million
Q1 2024 May 10, 2024	SELL	$528.82 - $599.43 $320,464 - $363,254	-606 Reduced 0.46%	130,356 $75.8 Million
Q4 2023 Feb 09, 2024	SELL	$431.41 - $532.94 $3.17 Million - $3.91 Million	-7,341 Reduced 5.31%	130,962 $69.5 Million
Q3 2023 Nov 14, 2023	SELL	$498.29 - $574.41 $1.83 Million - $2.11 Million	-3,678 Reduced 2.59%	138,303 $70 Million
Q2 2023 Aug 10, 2023	SELL	$508.46 - $591.13 $900,991 - $1.05 Million	-1,772 Reduced 1.23%	141,981 $74.1 Million
Q1 2023 May 01, 2023	SELL	$535.0 - $604.82 $474,010 - $535,870	-886 Reduced 0.61%	143,753 $82.9 Million
Q4 2022 Feb 14, 2023	BUY	$484.71 - $571.37 $32,475 - $38,281	67 Added 0.05%	144,639 $79.7 Million
Q3 2022 Nov 08, 2022	SELL	$507.19 - $604.49 $78,614 - $93,695	-155 Reduced 0.11%	144,572 $73.3 Million
Q2 2022 Aug 08, 2022	BUY	$500.9 - $612.21 $382,186 - $467,116	763 Added 0.53%	144,727 $78.6 Million
Q1 2022 May 05, 2022	BUY	$524.0 - $644.92 $101,656 - $125,114	194 Added 0.13%	143,964 $85 Million
Q4 2021 Feb 08, 2022	SELL	$569.0 - $667.24 $404,559 - $474,407	-711 Reduced 0.49%	143,770 $95.9 Million
Q3 2021 Nov 08, 2021	BUY	$509.53 - $609.78 $68,786 - $82,320	135 Added 0.09%	144,481 $82.5 Million
Q2 2021 Aug 12, 2021	BUY	$441.0 - $508.24 $194,040 - $223,625	440 Added 0.31%	144,346 $72.8 Million
Q1 2021 May 10, 2021	SELL	$439.85 - $518.83 $855,508 - $1.01 Million	-1,945 Reduced 1.33%	143,906 $65.7 Million
Q4 2020 Jan 27, 2021	SELL	$435.06 - $527.66 $732,205 - $888,051	-1,683 Reduced 1.14%	145,851 $67.9 Million
Q3 2020 Dec 01, 2020	SELL	$359.77 - $441.52 $1.28 Million - $1.57 Million	-3,564 Reduced 2.36%	147,534 $65.1 Million
Q2 2020 Jul 20, 2020	SELL	$275.2 - $362.34 $635,712 - $837,005	-2,310 Reduced 1.51%	151,098 $54.7 Million
Q1 2020 Apr 24, 2020	SELL	$255.3 - $340.05 $402,608 - $536,258	-1,577 Reduced 1.02%	153,408 $43.5 Million
Q4 2019 Jan 23, 2020	SELL	$271.93 - $328.04 $613,474 - $740,058	-2,256 Reduced 1.43%	154,985 $50.4 Million
Q3 2019 Oct 24, 2019	SELL	$268.46 - $305.43 $337,991 - $384,536	-1,259 Reduced 0.79%	157,241 $45.8 Million
Q2 2019 Jul 31, 2019	SELL	$257.51 - $295.55 $440,857 - $505,981	-1,712 Reduced 1.07%	158,500 $46.5 Million
Q1 2019 Apr 29, 2019	SELL	$212.17 - $273.72 $221,929 - $286,311	-1,046 Reduced 0.65%	160,212 $43.9 Million
Q4 2018 Jan 18, 2019	SELL	$208.47 - $251.98 $102,150 - $123,470	-490 Reduced 0.3%	161,258 $36.1 Million
Q3 2018 Oct 17, 2018	SELL	$205.57 - $244.32 $250,589 - $297,826	-1,219 Reduced 0.75%	161,748 $39.5 Million
Q2 2018 Jul 19, 2018	BUY	$203.14 - $219.53 $597,231 - $645,418	2,940 Added 1.84%	162,967 $33.8 Million
Q1 2018 Apr 19, 2018	BUY	$192.98 - $224.11 $542,466 - $629,973	2,811 Added 1.79%	160,027 $33 Million
Q4 2017 Jan 16, 2018	BUY	$182.03 - $200.37 $805,846 - $887,037	4,427 Added 2.9%	157,216 $29.9 Million
Q3 2017 Oct 24, 2017	BUY	$171.74 - $194.04 $26.2 Million - $29.6 Million	152,789	152,789 $28.9 Million

Others Institutions Holding TMO

# of Institutions

2,835

Shares Held

333M

Call Options Held

2.37M

Put Options Held

2.75M

View Full List

About THERMO FISHER SCIENTIFIC INC.

Ticker TMO
Exchange NYSE
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 391,788,992
Market Cap $207B
Description
Thermo Fisher Scientific Inc. offers life sciences solutions, analytical instruments, specialty diagnostics, and laboratory products and service worldwide. The company's Life Sciences Solutions segment offers reagents, instruments, and consumables for biological and medical research, discovery, and production of drugs and vaccines, as well as di...

More about TMO

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Davis R M Inc, based on Form 13F filings with the SEC.

News

Stay updated on Davis R M Inc with notifications on news.

Account